Toronto Immune & Digestive Health Institute Inc.

Toronto, Ontario M6A3B4

1 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study — Recruiting now